Pharmacology and clinical use of voriconazole

George Richard Thompson, James S. Lewis

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Importance of the field: Voriconazole is an extended-spectrum triazole developed specifically to target Aspergillus spp. and is now indicated as primary therapy in this circumstance. However, it has a broad spectrum of activity against both yeasts and molds and is also a viable treatment option in the treatment of other mycoses. Areas covered in this review: This review discusses the mechanism of action, the pharmacodynamics and pharmacokinetics and the most common mechanisms of resistance to this agent. An overview of therapeutic drug monitoring, drugdrug interactions and pivotal trials are also reviewed. What the reader will gain: The reader will gain further knowledge of the unique aspects of voriconazole compared to other currently available antifungal agents. Take home message: Voriconazole offers distinct advantages over several other antifungals. The side effect profile of voriconazole is unique compared to other triazole agents. Concern for drugdrug interactions due to a frequently shared common metabolic pathway has prompted heightened interest in the use of therapeutic drug monitoring for concerns of toxicity, drugdrug interactions and in attempts to ensure efficacy. These aspects as well as a review of important clinical information pertaining to voriconazole are discussed here.

Original languageEnglish (US)
Pages (from-to)83-94
Number of pages12
JournalExpert Opinion on Drug Metabolism and Toxicology
Volume6
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Clinical Pharmacology
Triazoles
Drug Monitoring
Pharmacodynamics
Pharmacokinetics
Mycoses
Monitoring
Antifungal Agents
Aspergillus
Molds
Metabolic Networks and Pathways
Pharmaceutical Preparations
Yeast
Toxicity
Fungi
Yeasts
Voriconazole

Keywords

  • Serum drug levels
  • Therapeutic drug monitoring
  • Voriconazole

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Pharmacology and clinical use of voriconazole. / Thompson, George Richard; Lewis, James S.

In: Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, No. 1, 01.2010, p. 83-94.

Research output: Contribution to journalArticle

@article{3d39cc3a41c842b18cf0ae1d71876c6e,
title = "Pharmacology and clinical use of voriconazole",
abstract = "Importance of the field: Voriconazole is an extended-spectrum triazole developed specifically to target Aspergillus spp. and is now indicated as primary therapy in this circumstance. However, it has a broad spectrum of activity against both yeasts and molds and is also a viable treatment option in the treatment of other mycoses. Areas covered in this review: This review discusses the mechanism of action, the pharmacodynamics and pharmacokinetics and the most common mechanisms of resistance to this agent. An overview of therapeutic drug monitoring, drugdrug interactions and pivotal trials are also reviewed. What the reader will gain: The reader will gain further knowledge of the unique aspects of voriconazole compared to other currently available antifungal agents. Take home message: Voriconazole offers distinct advantages over several other antifungals. The side effect profile of voriconazole is unique compared to other triazole agents. Concern for drugdrug interactions due to a frequently shared common metabolic pathway has prompted heightened interest in the use of therapeutic drug monitoring for concerns of toxicity, drugdrug interactions and in attempts to ensure efficacy. These aspects as well as a review of important clinical information pertaining to voriconazole are discussed here.",
keywords = "Serum drug levels, Therapeutic drug monitoring, Voriconazole",
author = "Thompson, {George Richard} and Lewis, {James S.}",
year = "2010",
month = "1",
doi = "10.1517/17425250903463878",
language = "English (US)",
volume = "6",
pages = "83--94",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Pharmacology and clinical use of voriconazole

AU - Thompson, George Richard

AU - Lewis, James S.

PY - 2010/1

Y1 - 2010/1

N2 - Importance of the field: Voriconazole is an extended-spectrum triazole developed specifically to target Aspergillus spp. and is now indicated as primary therapy in this circumstance. However, it has a broad spectrum of activity against both yeasts and molds and is also a viable treatment option in the treatment of other mycoses. Areas covered in this review: This review discusses the mechanism of action, the pharmacodynamics and pharmacokinetics and the most common mechanisms of resistance to this agent. An overview of therapeutic drug monitoring, drugdrug interactions and pivotal trials are also reviewed. What the reader will gain: The reader will gain further knowledge of the unique aspects of voriconazole compared to other currently available antifungal agents. Take home message: Voriconazole offers distinct advantages over several other antifungals. The side effect profile of voriconazole is unique compared to other triazole agents. Concern for drugdrug interactions due to a frequently shared common metabolic pathway has prompted heightened interest in the use of therapeutic drug monitoring for concerns of toxicity, drugdrug interactions and in attempts to ensure efficacy. These aspects as well as a review of important clinical information pertaining to voriconazole are discussed here.

AB - Importance of the field: Voriconazole is an extended-spectrum triazole developed specifically to target Aspergillus spp. and is now indicated as primary therapy in this circumstance. However, it has a broad spectrum of activity against both yeasts and molds and is also a viable treatment option in the treatment of other mycoses. Areas covered in this review: This review discusses the mechanism of action, the pharmacodynamics and pharmacokinetics and the most common mechanisms of resistance to this agent. An overview of therapeutic drug monitoring, drugdrug interactions and pivotal trials are also reviewed. What the reader will gain: The reader will gain further knowledge of the unique aspects of voriconazole compared to other currently available antifungal agents. Take home message: Voriconazole offers distinct advantages over several other antifungals. The side effect profile of voriconazole is unique compared to other triazole agents. Concern for drugdrug interactions due to a frequently shared common metabolic pathway has prompted heightened interest in the use of therapeutic drug monitoring for concerns of toxicity, drugdrug interactions and in attempts to ensure efficacy. These aspects as well as a review of important clinical information pertaining to voriconazole are discussed here.

KW - Serum drug levels

KW - Therapeutic drug monitoring

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=72949112971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949112971&partnerID=8YFLogxK

U2 - 10.1517/17425250903463878

DO - 10.1517/17425250903463878

M3 - Article

VL - 6

SP - 83

EP - 94

JO - Expert Opinion on Drug Metabolism and Toxicology

JF - Expert Opinion on Drug Metabolism and Toxicology

SN - 1742-5255

IS - 1

ER -